395
Views
2
CrossRef citations to date
0
Altmetric
Articles

Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country

, , , , , & show all
Pages 750-769 | Received 27 Feb 2019, Accepted 04 Oct 2019, Published online: 18 Oct 2019
 

Abstract

Objective: To assess the psychosocial impact of human papillomavirus (HPV) testing, colposcopy, and Pap-smear, as triage strategies after a Pap-smear with atypical squamous cells of undetermined significance (ASCUS). We also sought to evaluate the psychosocial impact based on the results of the strategies. Methods: Nested within a randomised pragmatic trial, which compared an immediate colposcopy, repeat Pap-smear, and high risk HPV test, we enrolled 675 women between 2012 and 2014. Participants completed surveys at enrollment, two weeks after triage test results, and 1 year thereafter to assess cervical cancer and HPV knowledge, self-esteem, anxiety and HPV impact (HIP). Results: Knowledge, self-esteem, anxiety and HIP improved with no differences among arms. At the baseline, 31.4% and 32.7% of the participants had state anxiety and trait anxiety, respectively, which decreased to 10.7% and 13.3% in the last survey. Compared to HPV-negative women, HPV-positive women in the second survey had worse HIP scores (HPV–: M 22.9 [SD: 15.20]; HPV+: M 35.9 [SD: 19.91]; p < 0.001), trait anxiety (HPV–: M 15.4 [SD 12.73]; HPV+: M 22.9 [SD 13.29]; p = 0.001), and state anxiety (HPV-: M 10.7 [SD 11.25]; HPV+: M 21.4 [SD 14.81]; p < 0.001). Conclusions: HPV testing as a triage strategy for women with ASCUS does not differ from colposcopies or Pap-smears in terms of psychosocial outcomes.

Highlights

  • HPV testing is suitable as a triage strategy for women with ASCUS.

  • Women with ASCUS need education and access to psychosocial support.

  • HPV-positive women as well as women with public health insurance are more in need of psychosocial support.

ClinicalTrials.gov Identifier:

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Committee for Research Development (CODI, for the term in Spanish) at the Universidad de Antioquia; Fondo de Investigación Docente of the Facultad Nacional de Salud Pública, Universidad de Antioquia; additionally, ASCUS-COL was supported by the Departamento Administrativo de Ciencia, Tecnología e Innovación Colombiano (COLCIENCIAS) (Grant 1115-459-21657).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.